Sign In  |  Register  |  About Daly City  |  Contact Us

Daly City, CA
September 01, 2020 1:20pm
7-Day Forecast | Traffic

  • Search Hotels in Daly City

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Glint Pharmaceuticals Receives FDA IND Acceptance for Clinical Study for Phase 1/2 Clinical Trial of Antibiotic Drug-Releasing Contact Lens, ACL5
Via 24-7 Press Release
Exposures Product Safety
Immediate Therapy for Urinary Incontinence in Women
Via PRLog
Exposures Product Safety
Transforming Global Music Scape: Introducing International Pop Phenomenon Vibe Exclusive
Via Get News
Topics Product Recall
Exposures Legal Product Safety
ZetrOZ Systems to Attend and Present at the Big Sky Athletic Training Sports Medicine Conference
Via Newswire.com
Exposures Product Safety
PsychedelicNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Commences Recruitment in FSD201 Phase 2 Clinical Trial
Via Investor Brand Network
Exposures Product Safety
Tickers CSE:HUGE HUGE
Cassava Sciences Stock Undervalued with Its $124 Price Target?
Via MarketBeat
Exposures Product Safety
Tickers AZN BIIB LLY MRK
TOP RANKED ROSEN LAW FIRM Encourages Y-mAbs Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - YMAB
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers YMAB
Dell Laser Consultants Announces Treatment of First Patient in Austin With the IC-8® Apthera™ IOL
Via Newswire.com
Exposures Product Safety
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Pricing of ~$8.4M Registered Direct Offering and Concurrent Private Placement
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Tickers NMRD
Ainnova Tech announces Dr. Maziar Lalezary, M.D. as Medical advisor and member of Medical Board
Via Zexprwire
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Skye Bioscience Obtains Central IRB Approval for Phase 2 Clinical Trial with SBI-100 Ophthalmic Emulsion
Via Newsfile
Exposures Product Safety
Tickers SKYE
cbdMD Maintains Commitment to Advocating for FDA Regulation Despite Recent News
Via Newsfile
Exposures Product Safety
Tickers YCBD
YMAB NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Y-mAbs Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - YMAB
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers YMAB
Report on 63 FDA-Approved Brand Names Released by Branding Agency, Brandsymbol
Via Press Advantage
Exposures Product Safety
Lobe Sciences, Ltd. Enters Collaborative Clinical Research Agreement with Integrative Headache Medicine of New York to Study the Effects of L-130 in the Treatment of Chronic Cluster Headache
Via FinancialNewsMedia
Exposures Product Safety
Tickers CSE:LOBE LOBEF
Mergers and Acquisitions in 2023 Off To A Strong Start
Via MarketBeat
Exposures Product Safety
Tickers AZN BNTX CVS GILD
How Could GSK's RSV Vaccine Change its Valuation?
Via MarketBeat
Exposures Product Safety
Tickers GSK MRNA PFE
BioMedNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Advances Novel Drug Candidate in Treating Alzheimer’s Symptoms
Via Investor Brand Network
Exposures Product Safety
Tickers IGC
How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
Via MarketBeat
Topics Workforce
Exposures Layoff Product Safety
Tickers EDIT ELEV FATE IPSC
InvestorNewsBreaks — VistaGen Therapeutics Inc. (NASDAQ: VTGN) Doses First Participants in PH10 Phase 1 Clinical Trial
Via Investor Brand Network
Exposures Product Safety
Tickers VTGN
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Reports Promising Initial Results from UK NHS Miboko Study
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Tickers NMRD
Medical Marijuana, Inc. Subsidiary HempMeds Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
Via NewMediaWire
Topics Cannabis Economy Lawsuit
Exposures Cannabis Financial Legal
Tickers MJNA
AMC Health Announces Appointment of Chief Operating Officer
Via Newswire.com
Exposures Product Safety
Mental Health Clinic Offering Transcranial Magnetic Stimulation in Santa Rosa Welcomes RN Paula Davey to the Team
Via Press Advantage
Exposures Product Safety
BioMedNewsBreaks – QSAM Biosciences Inc. (QSAM) to Present at Emerging Growth Conference
Via Investor Brand Network
Exposures Product Safety
Tickers QSAM
Wandercraft Receives FDA Clearance for Atalante, a Self-Balancing Device for Hands-Free Movement
Via Newswire.com
Exposures Product Safety
BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd.’s (NASDAQ: BVXV) NanoAb May Serve as Therapeutic and Prophylactic as Shown in Preclinical Study
Via Investor Brand Network
Exposures COVID-19 Product Safety
Tickers BVXV
ROSEN, A TOP RANKED LAW FIRM, Encourages Y-mAbs Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - YMAB
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers YMAB
Feline Fortune? Saint Julian Corey Van Hannegeyn IV went from $10,000 to $10,000,000 with Bizarre Inspiration from Stray Cats
Via AB Newswire
Topics Artificial Intelligence Product Recall
Exposures Artificial Intelligence Legal Product Safety
InvestorNewsBreaks — VistaGen Therapeutics Inc. (NASDAQ: VTGN) Set to Commence Antidepressant Nasal Spray Trial This Quarter
Via Investor Brand Network
Exposures Product Safety
Tickers VTGN
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 DalyCity.com & California Media Partners, LLC. All rights reserved.